Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | ADK | P55263 | 1/20 | 0.44 |
| ▸ | LGALS3 | P17931 | 1/20 | 0.43 |
| ▸ | GRK6 | P43250 | 2/20 | 0.42 |
| ▸ | CA1 | P00915 | 9/20 | 0.39 |
| ▸ | CA2 | P00918 | 9/20 | 0.39 |
| ▸ | CA9 | Q16790 | 3/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15436011 | 1.00 | TSHR (0.44) | TSHRADKLGALS3GRK6CA1 | |
| SCHEMBL16946211 | 1.00 | TSHR (0.44) | TSHRADKLGALS3GRK6CA1 | |
| SCHEMBL16941671 | 1.00 | TSHR (0.44) | TSHRADKLGALS3GRK6CA1 | |
| SCHEMBL15445169 | 1.00 | TSHR (0.44) | TSHRADKLGALS3GRK6CA1 | |
| SCHEMBL15436009 | 0.86 | TSHR (0.50) | TSHRGRK6CA1CA2CA9 | |
| SCHEMBL15436008 | 0.86 | TSHR (0.50) | TSHRGRK6CA1CA2CA9 | |
| SCHEMBL15445173 | 0.86 | TSHR (0.50) | TSHRGRK6CA1CA2CA9 | |
| SCHEMBL15436093 | 0.86 | SMN1; SMN2 (0.53) | TSHRCA1CA2CA9 | |
| SCHEMBL16946203 | 0.86 | TSHR (0.50) | TSHRGRK6CA1CA2CA9 | |
| SCHEMBL15436094 | 0.86 | SMN1; SMN2 (0.53) | TSHRCA1CA2CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2900678-B1 | MULTIMERIC MANNOSIDES, A PROCESS FOR PREPARING THE SAME AND THEIR USES AS A DRUG | CENTRE NAT RECH SCIENT (FR) | 2020-09-02 | — | — | EP | disclosed |
| US-10273313-B2 | Multimeric mannosides, a process for preparing the same and their uses as a drug | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2019-04-30 | — | — | US | disclosed |
| EP-2900678-A1 | MULTIMERIC MANNOSIDES, A PROCESS FOR PREPARING THE SAME AND THEIR USES AS A DRUG | Centre National de la Recherche Scientifique (C.N.R.S.) (FR) | 2015-08-05 | — | — | EP | disclosed |
| US-20150210781-A1 | MULTIMERIC MANNOSIDES, A PROCESS FOR PREPARING THE SAME AND THEIR USES AS A DRUG | NANTES UNIVERSITE (FR) | 2015-07-30 | — | — | US | disclosed |
| WO-2014016361-A1 | MULTIMERIC MANNOSIDES, A PROCESS FOR PREPARING THE SAME AND THEIR USES AS A DRUG | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2014-01-30 | — | — | WO | disclosed |
| EP-2690105-A1 | Mannose derivatives, a process for preparing the same and their uses as a drug | Centre National De La Recherche Scientifique (FR) | 2014-01-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10273313-B2 | Multimeric mannosides, a process for preparing the same and their uses as a drug | MANBA, MAN2A1, MAN2B2 | TSHR 4747/4885ADK 1279/4885LGALS3 114/4885 |
| US-20150210781-A1 | MULTIMERIC MANNOSIDES, A PROCESS FOR PREPARING THE SAME AND THEIR USES AS A DRUG | MANBA, MAN2A1, MAN2B2 | TSHR 4747/4885ADK 1279/4885LGALS3 114/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.